You are here

ALS

Biogen’s Experimental Drug Shows Promise for Genetic Form of ALS

Biogen’s Experimental Drug Shows Promise for Genetic Form of ALS

BioSpace

Ionis Pharmaceuticals

Flag link:

Cytokinetics' comeback attempt with second-gen drug is slammed by a PhII failure in ALS

Cytokinetics' comeback attempt with second-gen drug is slammed by a PhII failure in ALS

Endpoints

clinical trials

Flag link:

Biogen’s antisense ALS drug shows promise in early clinical trial

Biogen’s antisense ALS drug shows promise in early clinical trial

Fierce Biotech

clinical trials

Flag link:

Research Roundup: New CRISPR, ALS, Colon Cancer, Asthma and More

Research Roundup: New CRISPR, ALS, Colon Cancer, Asthma and More

BioSpace

Flag link:

ALS researchers at Harvard uncover new biomarker and drug target

ALS researchers at Harvard uncover new biomarker and drug target

Fierce Biotech

Lou Gehrig's disease

Flag link:

Biogen opts in for Ionis' ALS candidate, plans pivotal trial

Biogen opts in for Ionis' ALS candidate, plans pivotal trial

BioCentury

Ionis Pharmaceuticals

Flag link:

Researchers Cure ALS in Laboratory Animals Using Gene Therapy

Researchers Cure ALS in Laboratory Animals Using Gene Therapy

BioSpace

Lou Gehrig's disease

University of California

Flag link:

PARP inhibitors show promise for treating ALS and other brain disorders

PARP inhibitors show promise for treating ALS and other brain disorders

Fierce Biotech

PARP inhibitors

Flag link:

Orion takes repurposed heart failure drug into phase 3 for ALS

Orion takes repurposed heart failure drug into phase 3 for ALS

Fierce Biotech

clinical trials

Flag link:

ALS drug maker walks back plan to profit from right-to-try law following heavy criticism

ALS drug maker walks back plan to profit from right-to-try law following heavy criticism

Stat

BrainStorm Cell Therapeutics

right-to-try laws

clinical trials

Flag link:

Step right up: A biotech may soon sell an experimental med to dying ALS patients under ‘Right to Try’

Step right up: A biotech may soon sell an experimental med to dying ALS patients under ‘Right to Try’

Endpoints

right-to-try laws

BrainStorm Cell Therapeutics

Flag link:

Flex Pharma dumps midstage trials, cuts workforce, mulls a sale to stay alive

Flex Pharma dumps midstage trials, cuts workforce, mulls a sale to stay alive

Fierce Biotech

Flag link:

QurAlis Announces New Investors to Help Fund Drive to Cure ALS

QurAlis Announces New Investors to Help Fund Drive to Cure ALS

CP Wire

Flag link:

QurAlis Announces New Investors to Help Fund Drive to Cure ALS

Flag link:

Sangamo shares surge 3.4% on $12 mln ALS gene therapy collaboration with Pfizer

Sangamo shares surge 3.4% on $12 mln ALS gene therapy collaboration with Pfizer

Marketwatch

drug development

Flag link:

New target could yield treatment for Alzheimer's, ALS and more

New target could yield treatment for Alzheimer's, ALS and more

Fierce Biotech

drug development

Alzheimer's disease

Flag link:

The First ALS Drug In 22 Years Is Approved -- And It Costs 4 Times What It Does In Japan

The First ALS Drug In 22 Years Is Approved -- And It Costs 4 Times What It Does In Japan

Forbes

Flag link:

FDA OKs stem cell-gene therapy trial for ALS

FDA OKs stem cell-gene therapy trial for ALS

Drug Delivery Business

Flag link:

Backed by a biotech legend, two young entrepreneurs tackle one of the Holy Grails of R&D

Backed by a biotech legend, two young entrepreneurs tackle one of the Holy Grails of R&D

Endpoints

Lou Gehrig's disease

Flag link:

Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial

Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial

TheStreet.com

BrainStorm Cell Therapeutics

clinical trials

Flag link:

Pages